Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-24-000032
Filing Date
2024-08-09
Accepted
2024-08-09 16:27:36
Documents
102
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-20240630.htm   iXBRL 10-Q 1980199
2 EX-31.1 amrx-2024063010xqexx311.htm EX-31.1 10349
3 EX-31.2 amrx-2024063010xqexx312.htm EX-31.2 10266
4 EX-31.3 amrx-2024063010xqexx313.htm EX-31.3 10423
5 EX-32.1 amrx-2024063010xqexx321.htm EX-32.1 5619
6 EX-32.2 amrx-2024063010xqexx322.htm EX-32.2 5565
7 EX-32.3 amrx-2024063010xqexx323.htm EX-32.3 5653
  Complete submission text file 0001723128-24-000032.txt   10538151

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20240630.xsd EX-101.SCH 83333
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20240630_cal.xml EX-101.CAL 93273
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20240630_def.xml EX-101.DEF 390818
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20240630_lab.xml EX-101.LAB 736878
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20240630_pre.xml EX-101.PRE 552175
104 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20240630_htm.xml XML 1883700
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 241193188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)